Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Richard L. Perryman"'
Autor:
Richard L. Perryman, Ivan S. Login, Brian P. Conway, Michael O. Thorner, J. Leon Morris, Robert M. MacLeod, Alan D. Rogol
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 53:480-483
Medical therapy of prolactinomas with bromo-criptine has been demonstrated to reduce serum PRL levels to normal and also to reduce the size of such tumors. This size reduction may occur very rapidly. It is widely recognized that PRL levels rise again
Publikováno v:
Journal of Andrology. 2:233-242
Autor:
Ann J. Johanson, Alan D. Rogol, Martin B. Draznin, Michael J. Cronin, Michael O. Thorner, Kalman Kovacs, Wylie Vale, Eva Horvath, Richard L. Perryman
Publikováno v:
Journal of Clinical Investigation. 70:965-977
A 21-yr-old woman with Turner's syndrome presented with signs and symptoms of acromegaly. The serum growth hormone (GH) (95+/-9.4 ng/ml; mean+/-SEM) and somatomedin C (11 U/ml) levels were elevated, and an increase in GH levels after glucose instead
Autor:
Richard L. Perryman, Brian P. Conway, J. Leon Morris, Alan D. Rogol, Robert M. MacLeod, Michael O. Thorner, Stuart S. Howards, William H. Martin, Mark G. Wolfman
Publikováno v:
The Journal of clinical endocrinology and metabolism. 51(3)
Therapy for large prolactinomas remains controversial. Surgery is often unsuccessful in restoring endocrine function to normal. However, medical therapy with bromocriptine, a dopamine agonist, not only suppresses PRL levels, but may also lead to a re
Publikováno v:
The Journal of clinical endocrinology and metabolism. 53(4)
Pergolide mesylate is a synthetic ergoline with dopamine agonist properties. The endocrine profile was studied in a double blind crossover design in six normal males. Circulating PRL, TSH, GH, LH, FSH, and cortisol were measured in the basal state an